Treos Bio has tapped PPD to manage its first-in-human study on its lead cancer vaccine for colorectal cancer.
A recent study by the Tufts Center for the Study of Drug Development found that EDC systems still aren't efficiently accelerating clinical trials.
Indivumed and Helomics have teamed up to advance research in personalized cancer treatments.
PSI has opened an office in Taipei, making it its third new establishment set up this year in the Asia-Pacific region.
The new "Vant" added to the Vivek Ramaswamy family, with its aim of improving trials with artificial intelligence, announced its new CEO this week.
Concept Life Sciences has taken two new lab spaces at Alderley Park, adding 55 scientists to sustain its 30% year-over-year growth momentum.
Looking to boost its drug offerings, U.K. CRO Clinigen has paid £150.3 million (around $200 million) to buy out Quantum Pharma.
Biopharma intelligence firm Ozmosi has launched a database that aims to include almost all clinical trials around the world.
Antidote, which develops an online platform to match patients with researchers, just raised $11 million backed by Merck's GHI fund.
Greenphire integrates its patient payment solution into mProve's patient engagement mobile app.